Kronox Lab Sciences IPO GMP, Details, Guidance, Subscription Status, allotment @ Chanakyanipothi.com
👉A legacy of 31 Years.
India`s Oldest Investment & IPO website.
👉Most Trusted by Investors across India.
Table of Contents
Kronox Lab Sciences Post Listing Review:
What are the promoters of Kronox Lab Sciences IPO?
JOGINDERSINGH JASWAL, KETAN RAMANI AND PRITESH RAMANI are the promoters of the company.
What are the Objects of Kronox Lab Sciences IPO?
The Objects of the Offer are to carry out the Offer for Sale of up to 96,00,000 Equity Shares.
What is the business of Kronox Lab Sciences?
Juniper Hotels is a luxury hotel development and ownership company, and are the largest owner, by number of Keys of “Hyatt” affiliated hotels in India as of June 30, 2023. It has a portfolio of seven
hotels and serviced apartments and operate a total of 1,836 keys.
It is the only hotel development company in India with which Hyatt has a strategic investment. It owns 20% of Hyatt group affiliated hotel rooms in India as on June 30, 2023.
HHC is a global hospitality company with widely recognized, industry-leading brands and a tradition of innovation developed over 65 years, with a hotel portfolio consisting of 1,297 hotels and 311,171
rooms, across full service hotels and resorts, all-inclusive resorts, select service hotels, lifestyle hotels and other properties, as of June 30, 2023. It benefits from the experience of its key shareholders and are able to leverage their long-standing brand heritage, in-depth market understanding, operational experience, and the World of Hyatt loyalty program with over 40 million members as of June 30, 2023.
It currently owns a portfolio of seven hotels and serviced apartments which are located across six strategic cities in India, comprising of established metro cities (Mumbai and Delhi), emerging business destinations (Ahmedabad, Lucknow and Raipur) and upcoming tourist destinations (Hampi), providing guest and geographic diversification.
Kronox Lab Sciences manufactures High Purity Speciality Fine Chemicals for diversified end user industries. Its High Purity Speciality Fine Chemicals are used mainly as (i) reacting agents and raw material in the manufacturing of Active Pharmaceutical Ingredients (APIs); (ii) excipients in pharmaceutical formulations; (iii) reagents for scientific research and laboratory testing; (iv) ingredients in nutraceuticals formulations; (v) process intermediates and fermenting agents in biotech applications; (vi) ingredients in agrochemical formulations; (vii) ingredients in personal care products; (viii) refining agents in metal refineries; and (ix) ingredients in animal health products, amongst others. Its products are manufactured in accordance with industry standards like IP, BP, EP, JP, USP, FCC, LR, AR, GR and ACS in addition to custom manufacturing specifications, which differ from the industry standards, required by its customers in select cases. The company manufactures High Purity Speciality Fine Chemicals of various grades in particle sizes ranging from 10 mesh to 100 mesh. It believes that its focus on product development, diversity in product offerings, meeting quality standards and customer specifications and continuous process improvement has led to repeat orders from the customers over the years.
Its range of more than 185 products spanning across the family of phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, among others are supplied to customers in India and more than 20 countries globally.
In addition to the manufacturing of products in accordance with various domestic and international standards, the company also undertakes custom manufacturing to achieve high levels of purity, as specified by the client, having different purity levels than the prescribed industry standards. Custom manufacturing requires deep domain knowledge, expertise and understanding of the characteristics of each chemical and its compounds, including decreasing the level of existing impurities and the processes to be deployed to reach the desired level of purity.
The company has three (3) Manufacturing Facilities situated at Vadodara in Gujarat are close to the seaports of Mundra, Kandla, Hazira and Nhava Sheva. Its Manufacturing Facilities are cumulatively spread across 17,454 sq. mtrs.and as on December 31, 2023, have an aggregate installed capacity of 7,242 TPA. Its Unit I/II hold certifications such as, FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, ISO 45001:2018. Further, it has also obtained certifications such as Kosher, Halal, GMP and GLP for some of its products manufactured at Unit I.
For more information, click www.kronoxlabsciences.com
Kronox Lab Sciences IPO GMP, Particulars & Guidance
Kronox Lab Sciences IPO Details | |
IPO opens on | February 2024 |
IPO closes on | February 2024 |
Issue Type | Book Built Issue IPO |
Issue Size | 9600000 Sh /Rs ? Cr |
* Fresh Issue | – Sh /Rs -Cr |
* Offer for Sale | 9600000 Sh /Rs – Cr |
Face Value per share: | Rs. 10 |
Price Band | Rs. ? |
Retail Discount | Rs 0 per share |
Employee discount | Rs.0 per share |
Retail Lot Size | ? Shares |
Listing will at | BSE, NSE |
Shares offered in Kronox Lab Sciences? | Shares | Rs. in Cr |
QIB (75 %) | ? | ? |
NII (15 %) | ? | ? |
RII (10 %) | ? | ? |
Employees | – | – |
Total Shares | ? | ? |
Retail portion will be oversubscribed by | ? Forms. | |
How to apply in Kronox Lab Sciences IPO? | Amount Rs. | |
Min Retail Application | ? Sh | ? |
Max Retail Application | ? Sh | ? |
Small HNI (Min) application | ? Sh | ? |
Small HNI (Max) application | ? Sh | ? |
Big HNI Application | ? Sh | ? |
What is the timetable of Kronox Lab Sciences IPO? | |
IPO opens on | ? February 2024 |
IPO Closes on | ? February 2024 |
IPO Allotment on | ? February 2024 |
Unblocking of ASBA | ? February 2024 |
Credit of Shares | ? February 2024 |
Listing on | ? February 2024 |
Registered Office of Kronox Lab Sciences | |
Block No.353, Village Ekalbara, Padra, Vadodara 391 440, Gujarat, India | |
Who are the Lead Managers of Kronox Lab Sciences IPO? Pantomath Capital Advisors Pvt ltd |
|
Registrar to IPO | |
Kfin Technologies ltd |
Kronox Lab Sciences IPO Financial & Analytical Ratios | ||||
Year | Total Income | Net Profit | EPS | RoNW |
Rs. in Cr | Rs.in Cr | Rs. | % | |
2020-21 | 63.24 | 9.73 | 2.40 | 36 |
2021-22 | 83.34 | 13.63 | 3.49 | 34 |
2022-23 | 97.50 | 16.62 | 3.40 | 37 |
Book Value of the Share on 31.03.2023 | Rs. | 12.04 | ||
BV of the Share after the FPO | Rs. | ? | ||
Offer Price at Cap | Rs. | ? |
Kronox Lab Sciences IPO Ratio Analysis |
|
Price /EPS | ? |
Price/Book Value Ratio | ? |
Price/BV after IPO | ? |
How Kronox Lab Sciences IPO compares with the Peers?
Peer Comparison.
As on date of DRHP | FV | Total | PE |
Rs. | Income | Ratio of | |
Rs. In Cr | |||
Kronox | 10 | 98 | ? |
Tatva Chintan Pharmachem | 10 | 429 | 69.94 |
Tanfac Industries | 10 | 383 | 38.55 |
Newgen Chemicals | 10 | 691 | 75.61 |
Sigachi Industries | 1 | 309 | 56.22 |
DMCC Speciality Chemicals | 10 | 390 | 114.09 |
# This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Kronox Lab Sciences IPO Guidance
Kronox Lab Sciences manufactures High Purity Speciality Fine Chemicals for diversified end user industries. Its High Purity Speciality Fine Chemicals are used mainly as (i) reacting agents and raw material in the manufacturing of Active Pharmaceutical Ingredients (APIs); (ii) excipients in pharmaceutical formulations; (iii) reagents for scientific research and laboratory testing; (iv) ingredients in nutraceuticals formulations; (v) process intermediates and fermenting agents in biotech applications; (vi) ingredients in agrochemical formulations; (vii) ingredients in personal care products; (viii) refining agents in metal refineries; and (ix) ingredients in animal health products, amongst others
Size: ?
Financial Snapshot. ?
Quicklinks